BD PharmingenTM PE Mouse Anti-Human TRAIL-R2 (CD262)

Description

Flow cytometric analysis of TRAIL-R2 CD262 expression on U937 cells. Cells from the human U937 Histiocytic lymphoma, ATCC CRL-1593 cell line were stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; dashed line histogram or PE Mouse Anti-Human CD262 TRAIL-R2 antibody Cat. No. 565499 . The fluorescence histogram showing TRAIL-R2 CD262 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD FACSCanto II Flow Cytometer System. Flow cytometric analysis of TRAIL-R2 CD262 expression on U937 cells. Cells from the human U937 Histiocytic lymphoma, ATCC CRL-1593 cell line were stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; dashed line histogram or PE Mouse Anti-Human CD262 TRAIL-R2 antibody Cat. No. 565499 . The fluorescence histogram showing TRAIL-R2 CD262 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD FACSCanto II Flow Cytometer System. Show More Flow cytometric analysis of TRAIL-R2 CD262 expression on U937 cells. Cells from the human U937 Histiocytic lymphoma, ATCC CRL-1593 cell line were stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; dashed line histogram or PE Mouse Anti-Human CD262 TRAIL-R2 antibody Cat. No. 565499 . The fluorescence histogram showing TRAIL-R2 CD262 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD FACSCanto II Flow Cytometer System.